All data are based on the daily closing price as of November 13, 2026
s
Seegene
096530.KQ
18.45 USD
-0.39
-2.07%
Overview
Last close
18.45 usd
Market cap
840.46M usd
52 week high
29.06 usd
52 week low
14.31 usd
Target price
35.21 usd
Valuation
P/E
12.466
Forward P/E
70.4225
Price/Sales
2.2055
Price/Book Value
1.081
Enterprise Value
502.55M usd
EV/Revenue
1.3174
EV/EBITDA
3.7532
Key financials
Revenue TTM
381.48M usd
Gross Profit TTM
252.71M usd
EBITDA TTM
96.65M usd
Earnings per Share
1.51 usd
Dividend
0.97 usd
Total assets
818.13M usd
Net debt
N/A usd
About
Seegene, Inc. manufactures and sells molecular diagnostics products worldwide. It offers IVD products comprising respiratory disease detection products for respiratory infections; gastrointestinal disease detection products for gastrointestinal tract infections; human papillomavirus detection products; sexually transmitted infections causative pathogens detection products; tuberculosis detection products; drug resistance products; Magicplex sepsis real-time test for the detection and identification of sepsis causing pathogens; and meningitis detection products. The company also provides other products for the detection of SNPs in factor II, factor V, and MTHFR genes. The company has a collaboration with Werfen for the joint development of syndromic qPCR assays. Seegene, Inc. was founded in 2000 and is headquartered in Seoul, South Korea.